Menu
Back to User profile » Dr Qiang Wei
Papers published by Dr Qiang Wei:
Utilizing the Lactate Dehydrogenase-to-Albumin Ratio for Survival Prediction in Patients with Bladder Cancer After Radical Cystectomy
Xu H, Lin T, Ai J, Zhang J, Zhang S, Li Y, Zheng X, Zhang P, Wei Q, Tan P, Yang L
Journal of Inflammation Research 2023, 16:1733-1744
Published Date: 18 April 2023
Combined Treatment of Radiotherapy and Immunotherapy for Urological Malignancies: Current Evidence and Clinical Considerations
Lei H, Shi M, Xu H, Bai S, Xiong X, Wei Q, Yang L
Cancer Management and Research 2021, 13:1719-1731
Published Date: 24 February 2021
Evaluating the Effect of Cryptorchidism on Clinical Stage of Testicular Seminoma
Wang X, Chen Z, Qiu S, Cao D, Jin K, Li J, Chen B, Huang Y, Bao Y, Liu L, Wei Q
Cancer Management and Research 2020, 12:4883-4888
Published Date: 23 June 2020
Significance of tertiary Gleason pattern 5 in patients with Gleason score 7 after radical prostatectomy: a retrospective cohort study
Li J, Guo Y, Qiu S, He M, Jin K, Zheng X, Tu X, Liao X, Yang L, Wei Q
OncoTargets and Therapy 2019, 12:7157-7164
Published Date: 2 September 2019
Clinical characteristics of testicular seminoma in individuals in West China: a 10-year follow-up study
Chen Z, Qiu S, Cao D, Guo J, Chen B, Huang Y, Lai L, Bao Y, Dong Q, Liu L, Wei Q
Cancer Management and Research 2019, 11:7639-7645
Published Date: 14 August 2019
Predictive value of preoperative neutrophil-to-lymphocyte ratio in non-metastatic papillary renal cell carcinoma patients after receiving curative surgery
Tu X, Wang F, Chang T, Zhang C, Zhang M, Liu Z, Qiu S, Yang L, Wei Q
Cancer Management and Research 2019, 11:7515-7524
Published Date: 7 August 2019
Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis
Xu H, Tan P, Zheng X, Huang Y, Lin T, Wei Q, Ai J, Yang L
Drug Design, Development and Therapy 2019, 13:2215-2234
Published Date: 4 July 2019
The accumulation of metabolic syndrome components is associated with higher risk of positive surgical margin among patients with localized prostate cancer after radical prostatectomy
Zheng X, Qiu S, Liao X, Han X, Jin K, Yang L, Wei Q
OncoTargets and Therapy 2019, 12:1613-1620
Published Date: 26 February 2019